Population Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 Study

Li, Claire H.Pollock, Bruce G.Lyketsos, Constantine G.Vaidya, VijayDrye, Lea T.Kirshner, MargaretSorisio, DeniseBies, Robert R.DIADS-2 Research Group2025-05-222025-05-222013Li CH, Pollock BG, Lyketsos CG, et al. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study. J Clin Pharmacol. 2013;53(2):234-239. doi:10.1177/0091270012445793https://hdl.handle.net/1805/48310en-USPublisher PolicyAlzheimer diseaseAntidepressive agentsDepressionSertralinePopulation Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 StudyArticle